Results 161 to 170 of about 938,592 (268)

Targeting the NR1D1–IGF2BP2–V‐ATPase Axis With Hybrid Nanovesicles Restores Macrophage Rhythms to Reverse Sepsis‐Induced Immunosuppression

open access: yesAdvanced Science, Volume 13, Issue 62, 9 November 2026.
Sepsis disrupts immune‐cell rhythms and weakens bacterial clearance. Biomimetic nanovesicles combining erythrocyte and inflammation‐activated macrophage membranes deliver siNR1D1 to dysfunctional macrophages, restoring the NR1D1–IGF2BP2–V‐ATPase pathway, circadian regulation, phagolysosomal acidification, and antimicrobial defense.
Lang Chen   +13 more
wiley   +1 more source

Recurrence of Cryoglobulinemia Secondary to Hepatitis C in a Patient with HCV RNA (-) Negative in the Serum. [PDF]

open access: yesCase Rep Nephrol Dial, 2021
Sikorska-Wiśniewska M   +5 more
europepmc   +1 more source

Plant‐Derived Probiotics From Fermented Foods: Current Evidence on Antiviral Mechanisms and Gut–Lung Axis Modulation

open access: yesFood Frontiers, Volume 7, Issue 6, November 2026.
Plant‐derived probiotics from fermented foods exert anti‐respiratory virus effects via immune regulation, antiviral metabolites, and gut–lung axis, highlighting their advantages, key technologies, and application prospects. ABSTRACT Respiratory viral infections represent a major global public health threat, causing widespread morbidity, mortality, and ...
Yinghao Xing   +6 more
wiley   +1 more source

903 Protein Saver cards: the best alternative for dried blood spot storage at room temperature for HCV RNA. [PDF]

open access: yesSci Rep, 2022
Arca-Lafuente S   +7 more
europepmc   +1 more source

Hepatitis C Micro‐Elimination Through Patient Navigation of Individuals Experiencing Elevated Risk in a Mid‐Atlantic Regional Healthcare System in 2022 and 2023: A Cohort Study

open access: yesHealth Science Reports, Volume 9, Issue 11, November 2026.
ABSTRACT Background and Aims Hepatitis C virus (HCV) disproportionately impacts persons with substance use and mental health disorders. Micro‐elimination projects selectively foster diagnosis, treatment and reinfection of high priority demographic groups.
Adam Visconti   +3 more
wiley   +1 more source

Is Geenius HCV Supplemental Assay an Alternative to HCV Confirmatory Western Blot INNO‐LIA HCV Score in Repeatedly Reactive Blood Donations After First Line Screening?

open access: yesJournal of Clinical Laboratory Analysis, Volume 40, Issue 21, November 2026.
Serological testing of low prevalent blood donors: serological windows and false‐reactive screening results. There is moderate agreement between rapid immunochromatography test and western blot detecting anti‐HCV antibodies in blood donor sera. Discrepancies in results of immunochromatography test and western blot detecting anti‐HCV antibodies occur in
Zorana P. Kozić   +6 more
wiley   +1 more source

HCV RNA detection in hepatic and extrahepatic tissues after DAA-induced sustained virologic response. [PDF]

open access: yesBiomol Biomed
Mamdouh S   +6 more
europepmc   +1 more source

[Application of anti-HCV and HCV RNA detection in intravenous drug users]. [PDF]

open access: yesZhonghua Gan Zang Bing Za Zhi, 2021
Xu B   +6 more
europepmc   +1 more source

Kan donörü askerlerde hepatit C virus antikoru (anti - HCV)'nun seroprevalansı ve anti-HCV pozitif olanlarda HCV-RNA varlığının belirlenmesi

open access: yes, 2002
III ÖZET Kan donörü askerlerde Hepatit C virus antikoru ( anti-HCV )'nun seroprevalansı ve anti-HCV pozitif olanlarda HCV-RNA varlığının belirlenmesi Kan donörü askerlerde HCV seroprevalansı normal popülasyona göre yüksek bulunmaktadır.
GÜLHAN SEYHUN
core  

Home - About - Disclaimer - Privacy